GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Forward Dividend Yield %

Aion Therapeutic (XCNQ:AION) Forward Dividend Yield % : 0.00% (As of Apr. 14, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Forward Dividend Yield %?

As of today (2025-04-14), the Forward Annual Dividend Yield of Aion Therapeutic is 0.00%.

As of today (2025-04-14), the Trailing Annual Dividend Yield of Aion Therapeutic is 0.00%.

XCNQ:AION's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.935
* Ranked among companies with meaningful Forward Dividend Yield % only.

Aion Therapeutic's Dividends per Share for the three months ended in Jan. 2025 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Aion Therapeutic's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aion Therapeutic's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Aion Therapeutic's Forward Dividend Yield % falls into.


;
;

Aion Therapeutic Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Aion Therapeutic  (XCNQ:AION) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Aion Therapeutic Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aion Therapeutic Business Description

Traded in Other Exchanges
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.
Executives
Ismail Abdul Fattah Director or Senior Officer of 10% Security Holder
Douglas Craig Wilson Director or Senior Officer of 10% Security Holder
John Graham Simmonds Director, Senior Officer

Aion Therapeutic Headlines

No Headlines